Table 2.
Projected sample sizes across HIV prevention and treatment cascade outcomes (N=200).
| Cascade stage | Baseline, n (%) | 12-months, n (%) | Difference in proportions | Outcomes | |
| HIV test and risk reduction counseling in past 3 months | 75 (37.5) | 195 (95.0) | 57.5 | Increase in the proportion of TW who know their HIV status | |
| HIV positive | 46 (23.0) | 66 (33.0) | 10.0 | Identify new HIV infections in TW | |
| Linked to care | 22 (47.8) | 66 (100.0) | 52.2 | Increase in the proportion of HIV-positive TW linked to care | |
| Retained in care | 9 (40.9) | 60 (90.9) | 50.0 | Increase in the proportion of HIV-positive TW retained in care and treatment | |
| Adhered to ARTa | 11 (50.0) | 60 (90.9) | 40.9 | Increase in the proportion of HIV-positive TW prescribed ART | |
| Viral suppressed | 5 (45.5) | 50 (83.3) | 37.8 | Increase in the proportion of HIV positive TW who are virally suppressed | |
| HIV negative | 154 (77.0) | 134 (67.0) | 10.0 | Identify high-risk HIV-uninfected TW | |
| Completed referrals to HIV prevention services | 35 (22.7) | 70 (52.2) | 29.5 | Link high-risk HIV-uninfected TW to HIV prevention services, including access to pre-exposure prophylaxis | |
| STIb screening, risk reduction counseling, and treatment in past 3 months | 50 (25.0) | 200 (100.0) | 75.0 | Increase in the proportion of TW screened and treated for STIs | |
aART: antiretroviral therapy.
bSTI: sexually transmitted infection.